Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-phasic estradiol valerate + dienogest vs ethinylestradiol + levonorgestrel for oral contraception
2004-001613-34Phase 3Completed
- Sponsor
- Schering AG
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol valerate + dienogest in contraception (2 arms), sponsored by Schering AG. Started Dec 2004; status: completed.
02
Drugs
estradiol valerate + dienogest
03
Conditions
contraception
Beyond the preview
Go deeper on 2004-001613-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001613-34.